LOEWS CORP
Institutional investor · Portfolio as of Q4 2025
Top Holdings27 positions
CNA FINL CORP | 248.4M | $11.9B | 96.6% | $25.40 | +75.03% | 28 qtrssince 2019-Q1 | Unchanged 0 |
GILDAN ACTIVEWEAR INC | 888,655 | $55.5M | 0.5% | $61.64 | -10.52% | 1 qtr | New 50 |
BUILDERS FIRSTSOURCE INC | 280,000 | $28.8M | 0.2% | $102.89 | 0.00% | 1 qtr | New 49 |
AMCOR PLC | 3.2M | $26.3M | 0.2% | $43.28 | -2.31% | 3 qtrssince 2025-Q2 | Increased 37 |
ALLISON TRANSMISSION HLDGS I | 230,000 | $22.5M | 0.2% | $98.91 | +11.92% | 1 qtr | New 48 |
Meta Platforms Inc | 34,000 | $22.4M | 0.2% | $333.08 | +97.67% | 23 qtrssince 2020-Q2 | Increased 45 |
KINDER MORGAN INC DEL | 800,000 | $22M | 0.2% | $27.02 | +23.45% | 4 qtrssince 2025-Q1 | Increased 41 |
AVNET INC | 430,000 | $20.7M | 0.2% | $48.19 | +98.91% | 4 qtrssince 2025-Q1 | Increased 56 |
Alphabet Inc | 63,000 | $19.7M | 0.2% | $126.72 | +146.53% | 28 qtrssince 2019-Q1 | Decreased 0 |
JBS N.V. | 1.3M | $19.2M | 0.2% | $13.53 | -1.30% | 3 qtrssince 2025-Q2 | Unchanged 0 |
ALLY FINL INC | 360,000 | $16.3M | 0.1% | $26.47 | +67.59% | 11 qtrssince 2023-Q2 | Unchanged 0 |
Atlassian Corp | 100,000 | $16.2M | 0.1% | $162.93 | 0.00% | 1 qtr | New 48 |
WELLS FARGO & CO | 170,000 | $15.8M | 0.1% | $78.24 | +3.40% | 3 qtrssince 2025-Q2 | Decreased 0 |
CAPITAL ONE FINL CORP | 65,000 | $15.8M | 0.1% | $196.72 | +21.78% | 4 qtrssince 2025-Q1 | Increased 43 |
INGREDION INC | 140,000 | $15.4M | 0.1% | $106.77 | 0.00% | 1 qtr | New 48 |
BROOKFIELD CORP | 325,000 | $14.9M | 0.1% | $41.32 | +10.48% | 3 qtrssince 2025-Q2 | Increased 47 |
COMCAST CORP NEW | 440,000 | $13.2M | 0.1% | $27.66 | -3.89% | 28 qtrssince 2019-Q1 | Increased 55 |
Elevance Health Inc | 36,000 | $12.6M | 0.1% | $339.85 | +1.66% | 5 qtrssince 2024-Q4 | Decreased 0 |
Fair Isaac Corp | 7,000 | $11.8M | 0.1% | $1,690.62 | 0.00% | 1 qtr | New 40 |
AVANTOR INC | 1M | $11.5M | 0.1% | $13.46 | -14.86% | 3 qtrssince 2025-Q2 | Decreased 0 |
LOEWS CORP manages $12.3B across 27 positions as of Q4 2025. Top holdings: CNA (96.6%), GIL (0.5%), BLDR (0.2%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 1.5/5.0.
Active quarter - 10 new positions, 7 exits, 7 increased. Top move: AVT (INCREASED, conviction 56). Portfolio: $12.3B across 27 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR